These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 10926385

  • 1. Evaluating the efficacy of mucoactive aerosol therapy.
    Fuloria M, Rubin BK.
    Respir Care; 2000 Jul; 45(7):868-73. PubMed ID: 10926385
    [Abstract] [Full Text] [Related]

  • 2. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK.
    Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
    [Abstract] [Full Text] [Related]

  • 3. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF.
    Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [Abstract] [Full Text] [Related]

  • 4. Mucolytics, expectorants, and mucokinetic medications.
    Rubin BK.
    Respir Care; 2007 Jul; 52(7):859-65. PubMed ID: 17594730
    [Abstract] [Full Text] [Related]

  • 5. Aerosol Medications for Treatment of Mucus Clearance Disorders.
    Rubin BK.
    Respir Care; 2015 Jun; 60(6):825-9; discussion 830-32. PubMed ID: 26070577
    [Abstract] [Full Text] [Related]

  • 6. Other medications for aerosol delivery.
    Rubin BK.
    Paediatr Respir Rev; 2006 Jun; 7 Suppl 1():S76-9. PubMed ID: 16798603
    [Abstract] [Full Text] [Related]

  • 7. Mucus and mucins.
    Rubin BK.
    Otolaryngol Clin North Am; 2010 Feb; 43(1):27-34, vii-viii. PubMed ID: 20172254
    [Abstract] [Full Text] [Related]

  • 8. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK.
    Paediatr Respir Rev; 2006 Feb; 7 Suppl 1():S215-9. PubMed ID: 16798570
    [Abstract] [Full Text] [Related]

  • 9. Air and soul: the science and application of aerosol therapy.
    Rubin BK.
    Respir Care; 2010 Jul; 55(7):911-21. PubMed ID: 20587104
    [Abstract] [Full Text] [Related]

  • 10. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
    Disse B.
    Novartis Found Symp; 2002 Jul; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
    [Abstract] [Full Text] [Related]

  • 11. Inhaled interventions in cystic fibrosis: mucoactive and antibiotic therapies.
    Hurt K, Bilton D.
    Respiration; 2014 Jul; 88(6):441-8. PubMed ID: 25472021
    [Abstract] [Full Text] [Related]

  • 12. Mucus-controlling agents: past and present.
    King M, Rubin BK.
    Respir Care Clin N Am; 1999 Dec; 5(4):575-94. PubMed ID: 10565882
    [Abstract] [Full Text] [Related]

  • 13. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature.
    Boogaard R, de Jongste JC, Merkus PJ.
    Pediatr Pulmonol; 2007 Nov; 42(11):989-1001. PubMed ID: 17902149
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic aerosols and airway secretions.
    Rubin BK.
    J Aerosol Med; 1996 Nov; 9(1):123-30. PubMed ID: 10160202
    [Abstract] [Full Text] [Related]

  • 15. [Novel approach to respiratory pharmacology--pharmacological basis of cough, sputum and airway clearance].
    Miyata T.
    Yakugaku Zasshi; 2003 Dec; 123(12):987-1006. PubMed ID: 14689863
    [Abstract] [Full Text] [Related]

  • 16. Other mucoactive agents for cystic fibrosis.
    Bye PT, Elkins MR.
    Paediatr Respir Rev; 2007 Mar; 8(1):30-9. PubMed ID: 17419976
    [Abstract] [Full Text] [Related]

  • 17. Mucoactive medications and airway disease.
    Majima Y.
    Paediatr Respir Rev; 2002 Jun; 3(2):104-9. PubMed ID: 12297055
    [Abstract] [Full Text] [Related]

  • 18. Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance?
    Restrepo RD.
    Respir Care; 2007 Sep; 52(9):1159-73; discussion 1173-5. PubMed ID: 17716384
    [Abstract] [Full Text] [Related]

  • 19. Mucolytics in cystic fibrosis.
    Henke MO, Ratjen F.
    Paediatr Respir Rev; 2007 Mar; 8(1):24-9. PubMed ID: 17419975
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study.
    Crisafulli E, Coletti O, Costi S, Zanasi E, Lorenzi C, Lucic S, Fabbri LM, Bertini M, Clini EM.
    Clin Ther; 2007 Sep; 29(9):2001-9. PubMed ID: 18035199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.